Journal of Jilin University(Medicine Edition) ›› 2023, Vol. 49 ›› Issue (3): 811-815.doi: 10.13481/j.1671-587X.20230334
• Review • Previous Articles
Research progress in changes of hormone levels of patients with differentiated thyroid carcinoma during pregnancy and their effects on occurrence and development of disease
-
Received:2022-11-29Online:2023-05-28Published:2023-06-28
CLC Number:
- R736.1
Cite this article
share this article
| 1 | SUNG H， FERLAY J， SIEGEL R L， et al. Global cancer statistics 2020： GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin，2021，71（3）：209-249. |
| 2 | SMITH L H， DANIELSEN B， ALLEN M E， et al. Cancer associated with obstetric delivery： results of linkage with the California cancer registry［J］. Am J Obstet Gynecol， 2003， 189（4）： 1128-1135. |
| 3 | NOBRE G M， TRAMONTIN M Y， TREISTMAN N， et al. Pregnancy has no significant impact on the prognosis of differentiated thyroid cancer［J］. Arch Endocrinol Metab， 2021， 65（6）： 768-777. |
| 4 | DRIOUICH Y， HARAJ N E， AZIZ S， et al. Impact of pregnancy on papillary thyroid carcinoma prognosis［J］. Pan Afr Med J， 2021， 38： 261. |
| 5 | GLINOER D. The regulation of thyroid function in pregnancy：pathways of endocrine adaptation from physiology to pathology［J］.Endocr Rev， 1997，18（3）：404-433. |
| 6 | 周 玮， 黄 婷. 妊娠期甲状腺疾病监测与处理［J］. 中国实用妇科与产科杂志， 2017， 33（3）： 263-267. |
| 7 | 李晨阳， 滕卫平， 尚 涛. 甲状腺激素与妊娠［J］. 中华内分泌代谢杂志， 2003， 19（2）： 158-160. |
| 8 | HUANG S A. Physiology and pathophysiology of type 3 deiodinase in humans［J］.Thyroid，2005，15（8）： 875-881. |
| 9 | ALEXANDER E K， PEARCE E N， BRENT G A， et al. 2017 guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and the postpartum［J］. Thyroid， 2017， 27（3）： 315-389. |
| 10 | LEUNG A M， PEARCE E N， BRAVERMAN L E. Iodine nutrition in pregnancy and lactation［J］. Endocrinol Metab Clin North Am，2011，40（4）：765-777. |
| 11 | 王 溪， 王战建. 雌激素及抗雌激素药物与甲状腺癌［J］. 中华内分泌代谢杂志， 2014， 30（12）： 1128-1131. |
| 12 | LIANG J， SHANG Y F. Estrogen and cancer［J］. Annu Rev Physiol， 2013， 75： 225-240. |
| 13 | TAKAGI H， MITSUMORI K， ONODERA H， et al. Improvement of a two-stage carcinogenesis model to detect modifying effects of endocrine disrupting chemicals on thyroid carcinogenesis in rats［J］. Cancer Lett， 2002， 178（1）： 1-9. |
| 14 | NILSSON S， MÄKELÄ S， TREUTER E， et al. Mechanisms of estrogen action［J］. Physiol Rev， 2001， 81（4）： 1535-1565. |
| 15 | SANTIN A P， FURLANETTO T W. Role of estrogen in thyroid function and growth regulation［J］. J Thyroid Res， 2011， 2011： 875125. |
| 16 | VIVACQUA A， BONOFIGLIO D， ALBANITO L， et al.17beta-estradiol， genistein，and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30［J］.Mol Pharmacol， 2006， 70（4）： 1414-1423. |
| 17 | MANOLE D， SCHILDKNECHT B， GOSNELL B， et al. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms［J］. J Clin Endocrinol Metab， 2001， 86（3）： 1072-1077. |
| 18 | ALTUCCI L， ADDEO R， CICATIELLO L， et al. 17beta-estradiol induces cyclin D1 gene transcription， p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G（1）- arrested human breast cancer cells［J］. Oncogene， 1996， 12（11）： 2315-2324. |
| 19 | AURICCHIO F， MIGLIACCIO A， CASTORIA G， et al. Protein tyrosine phosphorylation and estradiol action［J］. Ann N Y Acad Sci， 1996， 784： 149-172. |
| 20 | KATO S， ENDOH H， MASUHIRO Y， et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase［J］. Science， 1995， 270（5241）： 1491-1494. |
| 21 | KIM-SCHULZE S， LOWE W L J R， SCHNAPER H W.Estrogen stimulates delayed mitogen-activated protein kinase activity in human endothelial cells via an autocrine loop that involves basic fibroblast growth factor［J］. Circulation， 1998， 98（5）： 413-421. |
| 22 | KOSSMEHL P， SHAKIBAEI M， COGOLI A， et al. Weightlessness induced apoptosis in normal thyroid cells and papillary thyroid carcinoma cells via extrinsic and intrinsic pathways［J］. Endocrinology， 2003， 144（9）： 4172-4179. |
| 23 | ZENG Q， CHEN G G， VLANTIS A C， et al. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway［J］. Cell Prolif， 2007， 40（6）： 921-935. |
| 24 | RAJORIA S， SURIANO R， SHANMUGAM A， et al. Metastatic phenotype is regulated by estrogen in thyroid cells［J］. Thyroid， 2010， 20（1）： 33-41. |
| 25 | BARANWAL S， ALAHARI S K. Molecular mechanisms controlling E-cadherin expression in breast cancer［J］. Biochem Biophys Res Commun， 2009， 384（1）： 6-11. |
| 26 | CHENG G Z， ZHANG W Z， WANG L H. Regulation of cancer cell survival， migration， and invasion by Twist： AKT2 comes to interplay［J］. Cancer Res， 2008， 68（4）： 957-960. |
| 27 | DONG W W， ZHANG H， LI J， et al. Estrogen induces metastatic potential of papillary thyroid cancer cells through estrogen receptor α and β［J］. Int J Endocrinol， 2013， 2013： 941568. |
| 28 | RAMSDEN J D. Angiogenesis in the thyroid gland［J］. J Endocrinol， 2000， 166（3）： 475-480. |
| 29 | HICKLIN D J， ELLIS L M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis［J］. J Clin Oncol， 2005， 23（5）：1011-1027. |
| 30 | SOH E Y， DUH Q Y， SOBHI S A， et al. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid［J］. J Clin Endocrinol Metab， 1997， 82（11）： 3741-3747. |
| 31 | KAMAT A， RAJORIA S， GEORGE A， et al. Estrogen-mediated angiogenesis in thyroid tumor microenvironment is mediated through VEGF signaling pathways［J］. Arch Otolaryngol Head Neck Surg， 2011， 137（11）： 1146-1153. |
| 32 | NWABUOBI C， ARLIER S， SCHATZ F， et al. hCG： biological functions and clinical applications［J］. Int J Mol Sci， 2017， 18（10）： 2037. |
| 33 | HERSHMAN J M. Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid ［J］. Best Pract Res Clin Endocrinol Metab， 2004， 18（2）： 249-265. |
| 34 | ZYGMUNT M， HERR F， KELLER-SCHOENWETTER S， et al. Characterization of human chorionic gonadotropin as a novel angiogenic factor［J］. J Clin Endocrinol Metab， 2002， 87（11）： 5290-5296. |
| 35 | SOH E Y， SOBHI S A， WONG M G， et al. Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines［J］. Surgery， 1996， 120（6）： 944-947. |
| 36 | ORIM F， BYCHKOV A， SHIMAMURA M， et al. Thyrotropin signaling confers more aggressive features with higher genomic instability on BRAF（V600E）- induced thyroid tumors in a mouse model［J］. Thyroid， 2014， 24（3）： 502-510. |
| 37 | LEONHARDT S A， EDWARDS D P. Mechanism of action of progesterone antagonists［J］. Exp Biol Med （Maywood）， 2002， 227（11）： 969-980. |
| 38 | VAN H K H， MENENDEZ-BOTET C J， STRONG E W，et al. Estrogen and progesterone receptor content in human thyroid disease［J］.Am J Clin Pathol，1993，99（2）： 175-181. |
| 39 | VANNUCCHI G， DE L S， PERRINO M， et al. Impact of estrogen and progesterone receptor expression on the clinical and molecular features of papillary thyroid cancer［J］. Eur J Endocrinol， 2015， 173（1）： 29-36. |
| 40 | AHN H Y， SONG R Y， AHN H S， et al. Expression of estrogen and progesterone receptors in papillary thyroid carcinoma in Korea［J］. Cancer Res Treat， 2021， 53（4）： 1204-1212. |
| 41 | GRAHAM J D， CLARKE C L. Physiological action of progesterone in target tissues［J］. Endocr Rev，1997，18（4）： 502-519. |
| 42 | HURD C， KHATTREE N， ALBAN P， et al. Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line［J］. J Biol Chem， 1995， 270（48）： 28507-28510. |
| 43 | HILTON H N， GRAHAM J D， CLARKE C L. Minireview： progesterone regulation of proliferation in the normal human breast and in breast cancer： a tale of two scenarios？［J］.Mol Endocrinol，2015，29（9）：1230-1242. |
| [1] | Zhiyuan XIAO,Bing SONG,Xinyu MA,Lianhui JIN,Tong ZHENG,Fang CHAI. Bioinformatics analysis on expression of apoptosis related gene CD44 in thyroid carcinoma tissue and its relationship with tumor invasion and immune cell infiltration [J]. Journal of Jilin University(Medicine Edition), 2023, 49(2): 473-481. |
| [2] | . Research progress in preoperative evaluation and prognostic related factors of low-risk papillary thyroid microcarcinoma [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1650-1656. |
| [3] | Wanyi GU,Cheng ZHI,Chunxia LIU. Intrathyroid thymic carcinoma: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1580-1585. |
| [4] | Wei JI,Jian DONG,Hong CHANG,Xuemei DU,Hong PENG,Hong XIE,Aimin ZHAO,Wei YAN,Juan BAI,Zhenxing PENG,Jinshu YIN. Influence of chinicopathological characteristics and BRAF V600E gene mutation in cervical lymph node metastasis in patients with papillary thyroid cancer [J]. Journal of Jilin University(Medicine Edition), 2022, 48(4): 995-1002. |
| [5] | Yaoyu FENG, Chenglei ZHANG, Lijuan HOU, Yifu WANG, Xiuling WU, Yunhai MA. Effect of miR-222-3p knockdown targeting PTEN on 131I radiotherapy resistance of thyroid cancer and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 677-686. |
| [6] | . [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 802-810. |
| [7] | Chunying ZHANG,Guangwei YIN,Mingda YOU,Hong CHEN,Yaojie HU,Yanbing LI,Chunyou CHEN. Inhibitory effects of siRNA targeting silencing TAK1 gene on proliferation and migration of thyroid cancer cells and p38 MAPK signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2021, 47(1): 110-117. |
| [8] | Jinghai DU,Xin GUO. Effects of BTg-3 on proliferation, invasion, migration and WNT / β-catenin signaling pathway of thyroid follicular carcinoma cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(6): 1234-1240. |
| [9] | DU Jinghai, CHEN Chunyou, GUO Xin, ZHANG Jing. Effects of silencing Kat5 gene on proliferation and apoptosis of thyroid papillary carcinoma cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 543-550. |
| [10] | ZHANG Lifang, CAI Lin, WANG Yunhua, ZHANG Keshi, WU Rina. Analysis on association between selenoprotein P polymorphism and risk of papillary thyriod carcinoma [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 383-388. |
| [11] | WANG Qi, SA Ri, LIN Qiuyu, ZHAO Hongguang. Protective effect of citric acid on salivary gland function in patients with differentiated thyroid cancer after first 131I treatment [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 911-915. |
| [12] | . Research progress in radiofrequency ablation in treatment of papillary thyroid carcinoma [J]. Journal of Jilin University(Medicine Edition), 2019, 45(03): 731-735. |
| [13] | HEI Lijuan, WANG Juanhong, WEI Wei, FANG Hangrong, DUAN Ying, MA Shifen, XU Junrong. Detection of interleukin-6 levels in serum and thyroid tissue of patients with papillary thyroid carcinoma and their significances [J]. Journal of Jilin University(Medicine Edition), 2019, 45(03): 601-605. |
| [14] | . Research progress in thyroid cancer related genes and their applications in clinical diagnosis [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 880-885. |
| [15] | ZHAO Zhiyan, SHENG Jindong, LIU Baoguo. Risk factors of malignant thyroid neoplasms and papillary thyroid cancer level Ⅵ lymph node metastasis [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 334-338. |
|
||
